D. E. Shaw & Co., Inc. Century Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.96 - $12.43 $178,598 - $278,891	-22,437 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.62 - $15.92 $85,988 - $117,808	7,400 Added 49.21%	22,437 $282,000
Q4 2021 Feb 14, 2022	SELL	$13.93 - $23.62 $81,058 - $137,444	-5,819 Reduced 27.9%	15,037 $238,000
Q3 2021 Nov 15, 2021	BUY	$20.8 - $31.93 $433,804 - $665,932	20,856 New	20,856 $525,000

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $61.8M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.